首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1819743

歐洲解剖病理學市場報告 2021-2031（範圍、細分、動態和競爭分析）

Europe Anatomic Pathology Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

出版日期: 2025年07月10日 | 出版商:

The Insight Partners | 英文 134 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

解剖病理學市場預計將大幅成長，到 2031 年將達到約 149.9993 億美元，高於 2023 年的 84.6165 億美元。這一成長代表著 2023 年至 2031 年的年複合成長率(CAGR) 為 7.4%。

執行摘要和歐洲市場概覽

在歐洲，解剖病理學市場主要分佈在幾個主要國家，包括德國、法國、英國、義大利、西班牙和其他地區。歐洲該市場的成長主要得益於癌症發生率的上升，尤其是子宮頸癌和乳癌。此外，衛生當局實施的各種癌症篩檢計畫旨在降低慢性病的盛行率，預計將為市場創造進一步的成長機會。

市場區隔分析

歐洲解剖病理學市場可以透過幾個部分進行分析：產品和服務、應用和最終用戶。

1. 產品與服務：市場分為服務、儀器和耗材。 2023年，儀器佔據了最大的市場。服務細分市場進一步分為組織病理學和細胞病理學，而儀器細分市場包括切片機、低溫恆溫器、自動染色機、組織處理機和其他相關工具。

2. 應用：市場根據應用細分為疾病診斷、藥物研發和其他領域。疾病診斷領域在2023年佔據最大佔有率，反映了解剖病理學在識別各種疾病方面的關鍵作用。

3. 最終使用者：最終使用者細分包括醫院、研究實驗室、診斷實驗室等。醫院在2023年佔據了最大的市場佔有率，凸顯了其在疾病診斷和治療中的核心作用。

市場展望

解剖病理學在診斷各種疾病（包括自體免疫疾病、腎臟和肝臟疾病以及癌症）中起著至關重要的作用。組織病理學專注於檢查疾病引起的組織變化，在癌症診斷中尤其重要。癌症仍然是全球面臨的重大健康挑戰，也是全球主要死亡原因之一。世界衛生組織 (WHO) 將癌症列為全球第二大死因。 2022 年，全球報告新增癌症病例約 2,000 萬例，2020 年癌症死亡人數近 1,000 萬人。光是在英國，每年就有約 392,000 例新發癌症病例，約 167,000 人死於癌症。

人口老化導致慢性腎臟病患病率上升，進一步凸顯了活體組織切片等解剖病理學技術在檢測癌症和腎臟疾病的重要性。隨著癌症和其他慢性疾病發生率的上升，醫療保健提供者、政府機構和機構越來越重視加強疾病的診斷和治療。這一趨勢預計將推動歐洲解剖病理學市場的成長。

特定國家的見解

歐洲解剖病理學市場主要包括英國、德國、法國、義大利、西班牙等國家。 2023年，德國佔了最大的市場佔有率，這主要歸功於細胞學檢查的廣泛認可，尤其是在子宮頸癌篩檢計畫中。德國政府一直積極改善醫療基礎設施，特別是透過其子宮頸癌篩檢計畫。該計畫於2020年1月進行了更新，將35歲及以上女性每三年進行一次細胞學和人類乳突病毒(HPV)聯合檢測納入其中。

子宮頸癌病例的增加促使德國各地紛紛推行篩檢措施。近期研究表明，細胞學檢查仍然是子宮頸癌篩檢的重要組成部分，大規模進行高風險HPV初次篩檢或有助於最終消除子宮頸癌。德國眾多知名研究機構的存在也促進了旨在早期發現和預防疾病的創新病理學檢測的發展。例如，科隆病理研究所每年處理約4萬份手術標本，並進行150次屍檢，彰顯了德國強大的病理學服務。

公司簡介

歐洲解剖病理學市場的主要參與者包括羅氏公司 (F. Hoffmann-La Roche Ltd)、貝克曼庫爾特公司 (Beckman Coulter Inc)、豪洛捷公司 (Hologic Inc)、安捷倫科技公司 (Agilent Technologies Inc)、Diapath SpA、Bio SB、默克公司 (Merck KGaA) 和 PHC Holdings Corporation 等。這些公司正在採用各種策略，包括市場擴張、產品創新和併購，以增強其產品組合併提高其市場佔有率。

總之，受癌症和慢性病發病率上升以及醫療技術和篩檢措施不斷進步的推動，歐洲解剖病理學市場有望大幅成長。

In Europe, the anatomic pathology market is divided into several key countries, including Germany, France, the UK, Italy, Spain, and other regions. The growth of this market in Europe is primarily driven by the increasing incidence of cancers, particularly cervical and breast cancer. Additionally, various cancer screening initiatives implemented by health authorities aim to lower the prevalence of chronic diseases, which is expected to create further growth opportunities in the market.

Market Segmentation Analysis

The European anatomic pathology market can be analyzed through several segments: products and services, applications, and end users.

1. Products and Services: The market is categorized into services, instruments, and consumables. In 2023, instruments accounted for the largest market share. The services segment is further divided into histopathology and cytopathology, while the instruments segment includes microtomes, cryostats, automatic stainers, tissue processors, and other related tools.

2. Applications: The market is segmented based on applications into disease diagnosis, drug discovery and development, and other areas. The disease diagnosis segment held the largest share in 2023, reflecting the critical role of anatomic pathology in identifying various diseases.

3. End Users: The end-user segmentation includes hospitals, research laboratories, diagnostic laboratories, and others. Hospitals represented the largest share of the market in 2023, highlighting their central role in disease diagnosis and treatment.

Market Outlook

Anatomic pathology plays a crucial role in diagnosing various diseases, including autoimmune disorders, kidney and liver diseases, and cancers. Histopathology, which focuses on examining tissue changes due to diseases, is particularly vital in cancer diagnosis. Cancer remains a significant global health challenge, being one of the leading causes of death worldwide. The World Health Organization (WHO) identifies cancer as the second leading cause of mortality globally. In 2022, approximately 20 million new cancer cases were reported, and nearly 10 million deaths were attributed to cancer in 2020. In the UK alone, around 392,000 new cancer diagnoses occur annually, with approximately 167,000 deaths each year due to the disease.

The rising prevalence of chronic kidney disease, driven by an aging population, further emphasizes the importance of anatomic pathology techniques such as biopsies for detecting cancer and kidney diseases. As the incidence of cancer and other chronic diseases rises, healthcare providers, government agencies, and institutions are increasingly focused on enhancing disease diagnosis and treatment initiatives. This trend is expected to propel the growth of the anatomic pathology market in Europe.

Country-Specific Insights

The European anatomic pathology market includes key countries such as the UK, Germany, France, Italy, Spain, and others. Germany held the largest market share in 2023, largely due to the significant recognition of cytology, especially in relation to cervical cancer screening programs. The German government has been proactive in improving medical infrastructure, particularly through its cervical cancer screening program, which was updated in January 2020 to include co-testing for cytology and human papillomavirus (HPV) every three years for women aged 35 and older.

The increase in cervical cancer cases has led to a rise in screening initiatives across Germany. Recent studies indicate that cytology remains a critical component of cervical cancer screening, and the implementation of mass primary high-risk HPV screening may contribute to the eventual elimination of cervical cancer. The presence of esteemed research institutions in Germany also supports the advancement of innovative pathology tests aimed at early disease detection and prevention. For instance, the Institute for Pathology in Cologne processes around 40,000 surgical specimens and conducts 150 postmortems annually, underscoring the robust pathology services available in the country.

Company Profiles

Key players in the European anatomic pathology market include F. Hoffmann-La Roche Ltd, Beckman Coulter Inc, Hologic Inc, Agilent Technologies Inc, Diapath S.p.A., Bio SB, Merck KGaA, and PHC Holdings Corporation, among others. These companies are employing various strategies, including market expansion, product innovation, and mergers and acquisitions, to enhance their offerings and increase their market presence.

In conclusion, the European anatomic pathology market is poised for substantial growth, driven by the rising prevalence of cancer and chronic diseases, alongside ongoing advancements in medical technology and screening initiatives.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Europe Anatomic Pathology Market Landscape

4.1 Overview
4.2 PEST Analysis

5. Europe Anatomic Pathology Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increase in Prevalence of Cancer and Kidney Diseases
- 5.1.2 Rise in Number of Strategic Initiatives
5.2 Market Restraints
- 5.2.1 Lack of Skilled Professionals
- 5.2.2 Stringent Government Regulations
5.3 Market Opportunities
- 5.3.1 Growing Focus on Personalized Medicines
5.4 Future Trends
- 5.4.1 Integration of Artificial Intelligence and Machine Learning
5.5 Impact of Drivers and Restraints:

6. Anatomic Pathology Market - Europe Analysis

6.1 Europe Anatomic Pathology Market Revenue (US$ Million), 2021-2031
6.2 Europe Anatomic Pathology Market Forecast Analysis

7. Europe Anatomic Pathology Market Analysis - by Product and Services

7.1 Services
- 7.1.1 Overview
- 7.1.2 Services: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Instruments
- 7.2.1 Overview
- 7.2.2 Instruments: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Consumables
- 7.3.1 Overview
- 7.3.2 Consumables: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)

8. Europe Anatomic Pathology Market Analysis - by Application

8.1 Disease Diagnosis
- 8.1.1 Overview
- 8.1.2 Disease Diagnosis: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Drug Discovery and Development
- 8.2.1 Overview
- 8.2.2 Drug Discovery and Development: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Others
- 8.3.1 Overview
- 8.3.2 Others: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)

9. Europe Anatomic Pathology Market Analysis - by End User

9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Research Laboratories
- 9.2.1 Overview
- 9.2.2 Research Laboratories: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Diagnostic Laboratories
- 9.3.1 Overview
- 9.3.2 Diagnostic Laboratories: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Others
- 9.4.1 Overview
- 9.4.2 Others: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)

10. Europe Anatomic Pathology Market - Country Analysis

10.1 Europe
- 10.1.1 Europe Anatomic Pathology Market Overview
- 10.1.2 Europe Anatomic Pathology Market - Revenue and Forecast Analysis - by Country
  - 10.1.2.1 United Kingdom: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.1.1 United Kingdom: Europe Anatomic Pathology Market Breakdown, by Product and Services
      - 10.1.2.1.1.1 United Kingdom: Europe Anatomic Pathology Market Breakdown, by Services
      - 10.1.2.1.1.2 United Kingdom: Europe Anatomic Pathology Market Breakdown, by Instruments
    - 10.1.2.1.2 United Kingdom: Europe Anatomic Pathology Market Breakdown, by Application
    - 10.1.2.1.3 United Kingdom: Europe Anatomic Pathology Market Breakdown, by End User
  - 10.1.2.2 Germany: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.2.1 Germany: Europe Anatomic Pathology Market Breakdown, by Product and Services
      - 10.1.2.2.1.1 Germany: Europe Anatomic Pathology Market Breakdown, by Services
      - 10.1.2.2.1.2 Germany: Europe Anatomic Pathology Market Breakdown, by Instruments
    - 10.1.2.2.2 Germany: Europe Anatomic Pathology Market Breakdown, by Application
    - 10.1.2.2.3 Germany: Europe Anatomic Pathology Market Breakdown, by End User
  - 10.1.2.3 France: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.3.1 France: Europe Anatomic Pathology Market Breakdown, by Product and Services
      - 10.1.2.3.1.1 France: Europe Anatomic Pathology Market Breakdown, by Services
      - 10.1.2.3.1.2 France: Europe Anatomic Pathology Market Breakdown, by Instruments
    - 10.1.2.3.2 France: Europe Anatomic Pathology Market Breakdown, by Application
    - 10.1.2.3.3 France: Europe Anatomic Pathology Market Breakdown, by End User
  - 10.1.2.4 Italy: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.4.1 Italy: Europe Anatomic Pathology Market Breakdown, by Product and Services
      - 10.1.2.4.1.1 Italy: Europe Anatomic Pathology Market Breakdown, by Services
      - 10.1.2.4.1.2 Italy: Europe Anatomic Pathology Market Breakdown, by Instruments
    - 10.1.2.4.2 Italy: Europe Anatomic Pathology Market Breakdown, by Application
    - 10.1.2.4.3 Italy: Europe Anatomic Pathology Market Breakdown, by End User
  - 10.1.2.5 Spain: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.5.1 Spain: Europe Anatomic Pathology Market Breakdown, by Product and Services
      - 10.1.2.5.1.1 Spain: Europe Anatomic Pathology Market Breakdown, by Services
      - 10.1.2.5.1.2 Spain: Europe Anatomic Pathology Market Breakdown, by Instruments
    - 10.1.2.5.2 Spain: Europe Anatomic Pathology Market Breakdown, by Application
    - 10.1.2.5.3 Spain: Europe Anatomic Pathology Market Breakdown, by End User
  - 10.1.2.6 Rest of Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.6.1 Rest of Europe Anatomic Pathology Market Breakdown, by Product and Services
      - 10.1.2.6.1.1 Rest of Europe Anatomic Pathology Market Breakdown, by Services
      - 10.1.2.6.1.2 Rest of Europe Anatomic Pathology Market Breakdown, by Instruments
    - 10.1.2.6.2 Rest of Europe Anatomic Pathology Market Breakdown, by Application
    - 10.1.2.6.3 Rest of Europe Anatomic Pathology Market Breakdown, by End User

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in Europe Anatomic Pathology Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 F. Hoffmann-La Roche Ltd
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Beckman Coulter Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Hologic Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Agilent Technologies Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Diapath S.p.A.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Bio SB
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Merck KGaA
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 PHC Holdings Corporation
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. Europe Anatomic Pathology Market Segmentation
Table 2. Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Table 3. Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million) - by Product and Services
Table 4. Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 5. Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 6. United Kingdom: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
Table 7. United Kingdom: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 8. United Kingdom: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
Table 9. United Kingdom: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 10. United Kingdom: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 11. Germany: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
Table 12. Germany: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 13. Germany: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
Table 14. Germany: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 15. Germany: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 16. France: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
Table 17. France: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 18. France: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
Table 19. France: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 20. France: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 21. Italy: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
Table 22. Italy: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 23. Italy: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
Table 24. Italy: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 25. Italy: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 26. Spain: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
Table 27. Spain: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 28. Spain: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
Table 29. Spain: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 30. Spain: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 31. Rest of Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
Table 32. Rest of Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 33. Rest of Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
Table 34. Rest of Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 35. Rest of Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 36. Recent Organic Growth Strategies in Europe Anatomic Pathology Market
Table 37. Recent Inorganic Growth Strategies in the Europe Anatomic Pathology Market
Table 38. Glossary of Terms, Anatomic Pathology Market

List Of Figures

Figure 1. Europe Anatomic Pathology Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Europe Anatomic Pathology Market - Key Market Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Europe Anatomic Pathology Market Revenue (US$ Million), 2021-2031
Figure 6. Europe Anatomic Pathology Market Share (%) - by Product and Services (2023 and 2031)
Figure 7. Services: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Instruments: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Consumables: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Europe Anatomic Pathology Market Share (%) - by Application (2023 and 2031)
Figure 11. Disease Diagnosis: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Drug Discovery and Development: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Others: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Europe Anatomic Pathology Market Share (%) - by End User (2023 and 2031)
Figure 15. Hospitals: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Research Laboratories: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. Diagnostic Laboratories: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Others: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Europe Anatomic Pathology Market Breakdown, by Key Countries - Revenue (2023) (US$ Million)
Figure 20. Europe Anatomic Pathology Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 21. United Kingdom: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
Figure 22. Germany: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
Figure 23. France: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
Figure 24. Italy: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
Figure 25. Spain: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
Figure 26. Rest of Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
Figure 27. Growth Strategies in Europe Anatomic Pathology Market